Large Clinical Trials Webinar

Large Clinical Trials - Webinar

Presenting five of the highest-rated research works which are part of our scientific programme.

Watch here the large clinical trial results presented during ESO-WSO 2020 Webinar, including major clinical trials on the assessment and efficacy of Fluoxetine, endovascular thrombectomy with or without intravenous alteplase, and more.

EFFECTS

Efficacy of fluoxetine – a randomised controlled trial in stroke

Presentor: Erik Lundström, MD, Associate Prof. of Neurology, Institute of Neuroscience, Uppsala University, Sweden

BASICS

A randomized acute stroke trial of endovascular therapy in acute basilar artery occlusion

Presentor: Dr. Wouter Schonewille, Department of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands

DIRECT-MT

Endovascular thrombectomy with or without intravenous alteplase in acute stroke

Presentor: Jianmin Liu, Changhai Hospital in Shanghai, Department of Neurosurgery, Cerebrovascular Center, China

AFFINITY

Assessment of fluoxetine in stroke recovery – a randomised, double-blind, placebo-controlled trial

Presentor: Prof. Graeme Hankey, Department of Neurology, Medical School, Faculty of Health and Medical Sciences, University of Western Australia

ASCOT

Effect of lipid-lowering, blood pressure regimens and blood pressure variability

Presentor: Dr William Whiteley, University of Edinburgh, Honorary Consultant Neurologist, NHS Lothian, Senior Clinical Fellow, NDPH, University of Oxford

 

There have been many recent advances in stroke care, and the need for us to provide high-quality care for people with stroke is as critical now as ever. We are sure you will find these sessions interesting and exciting during this difficult time where our work, personal, and social lives are so disrupted.

ABOUT THIS WEBINAR

We are delighted to present you with five of the highest-rated research works which are part of our scientific programme

AGENDA

  • Trial 1: Efficacy of Fluoxetine: A Randomized Controlled Trial in Stroke (Effects) Assoc. Prof. Erik Lundström (Sweden) Department of Neuroscience, Neurology, Uppsala University, Akademiska Sjukhuset, Uppsala, Sweden
  • Trial 2: Assessment of Fluoxetine in Stroke Recovery (Affinity): Results of a Double-blind, Placebo-controlled, Randomised Trial Prof. Graeme Hankey (Australia) Department of Neurology, Medical School, Faculty of Health and Medical Sciences, The University of Western Australia
  • Trial 3: A Randomized Trial of Direct Endovascular Thrombectomy Versus Thrombectomy Preceded by Intravenous Alteplase in Acute Ischemic Stroke Prof. Jianmin Liu (China) Changhai Hospital in Shanghai, Department of Neurosurgery, Cerebrovascular Center, China
  • Trial 4: The Basilar Artery International Collaboration Study (Basics): A Randomized Controlled Trial of Endovascular Therapy in Basilar Artery Occlusion Dr. Wouter Schonewille (Netherlands) Department of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands
  • Trial 5: Ascot Trial: The Effect of Randomisation to Atorvastatin or Placebo, and Amlodipine-based or Beta-blocker-based Regime on 20-year Incidence of Stroke or Dementia Dr. William Whiteley (UK) Senior Lecturer, CCBS, University of Edinburgh, Honorary Consultant Neurologist, NHS Lothian, Senior Clinical Fellow, NDPH, University of Oxford